Feedback / Questions
BH-30236 - BlossomHill Therap
https://www.globenewswire.com/news-release/2025/11/03/3179371/0/en/BlossomHill-Therapeutics-to-Present-at-the-67th-American-Society-of-Hematology-ASH-Annual-Meeting-on-Design-of-Phase-1-1b-Study-of-BH-30236-an-Oral-Macrocyclic-CLK-Inhibitor-in-R-R.html
Nov 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next